Leishmaniasis is a group of disease caused by the intracellular protozoan parasite of the
genus Leishmania. Infection by different species of Leishmania results in various host …

Cutaneous leishmaniasis (CL) is a global public health issue. Conventional treatments have
substantial costs, side effects, and parasite resistance. Due to easy application and …

To ensure success in the development and manufacturing of nanomedicines requires forces
of an interdisciplinary team that combines medicine, engineering, chemistry, biology …

Leishmaniasis is a prevalent parasitic infection belonging to neglected tropical diseases. It is
caused by Leishmania protozoan parasites transmitted by sandflies and it is responsible for …

Modern subunit vaccines with purified or recombinant antigens are important alternatives to
the traditional vaccines. However, there remains a big challenge to elicit potent antibody …

Visceral leishmaniasis (VL) is a vector-borne disease affecting humans and domestic
animals that constitutes a serious public health problem in many countries. Although many …

Although a great deal of knowledge has been gained from studies on the immunobiology of
leishmaniasis, there is still no universally acceptable, safe, and effective vaccine against the …

The use of an appropriate delivery system has recently emerged as a promising approach
for the development of effective vaccination against visceral leishmaniasis (VL). Here, we …

Nanotechnology in Diagnosis, Treatment and Prophylaxis of Infectious Diseases delivers
comprehensive coverage of the application of nanotechnology to pressing problems in …

Introduction: Leishmaniasis is a neglected tropical infection caused by several species of
intracellular protozoan parasites of the genus Leishmania. It is strongly believed that the …